PI3K inhibitors are finally coming of age

B Vanhaesebroeck, MWD Perry, JR Brown… - Nature reviews Drug …, 2021 - nature.com
Abstract Overactive phosphoinositide 3-kinase (PI3K) in cancer and immune dysregulation
has spurred extensive efforts to develop therapeutic PI3K inhibitors. Although progress has …

[HTML][HTML] Targeting PI3K/AKT signaling pathway in obesity

MS Savova, LV Mihaylova, D Tews, M Wabitsch… - Biomedicine & …, 2023 - Elsevier
Obesity is a disorder with an increasing prevalence, which impairs the life quality of patients
and intensifies societal health care costs. The development of safe and innovative …

[HTML][HTML] The PI3K/AKT pathway in obesity and type 2 diabetes

X Huang, G Liu, J Guo, Z Su - International journal of biological …, 2018 - ncbi.nlm.nih.gov
Obesity and type 2 diabetes mellitus are complicated metabolic diseases that affect multiple
organs and are characterized by hyperglycaemia. Currently, stable and effective treatments …

Biochemical and cellular properties of insulin receptor signalling

RA Haeusler, TE McGraw, D Accili - Nature reviews Molecular cell …, 2018 - nature.com
The mechanism of insulin action is a central theme in biology and medicine. In addition to
the rather rare condition of insulin deficiency caused by autoimmune destruction of …

[HTML][HTML] Metabolic control of longevity

C López-Otín, L Galluzzi, JMP Freije, F Madeo… - Cell, 2016 - cell.com
Several metabolic alterations accumulate over time along with a reduction in biological
fitness, suggesting the existence of a" metabolic clock" that controls aging. Multiple inborn …

The present and future of PI3K inhibitors for cancer therapy

P Castel, E Toska, JA Engelman, M Scaltriti - Nature cancer, 2021 - nature.com
Abstract Phosphoinositide 3-kinase (PI3K) signaling regulates cellular proliferation, survival
and metabolism, and its aberrant activation is one of the most frequent oncogenic events …

Cancer-associated PIK3CA mutations in overgrowth disorders

RR Madsen, B Vanhaesebroeck, RK Semple - Trends in molecular …, 2018 - cell.com
PIK3CA is one of the most commonly mutated genes in solid cancers. PIK3CA mutations are
also found in benign overgrowth syndromes, collectively known as PIK3CA-related …

Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?

AJ Klil-Drori, L Azoulay, MN Pollak - Nature reviews Clinical oncology, 2017 - nature.com
The prevalence of obesity, of type 2 diabetes mellitus (T2DM), and of cancer are all
increasing globally. The relationships between these diseases are complex, and thus …

Hyperinsulinemia: a cause of obesity?

KA Erion, BE Corkey - Current obesity reports, 2017 - Springer
Abstract Purpose of Review This perspective is motivated by the need to question dogma
that does not work: that the problem is insulin resistance (IR). We highlight the need to …

Inhibition of the IL-17A axis in adipocytes suppresses diet-induced obesity and metabolic disorders in mice

A Teijeiro, A Garrido, A Ferre, C Perna, N Djouder - Nature Metabolism, 2021 - nature.com
Overnutrition causes obesity, a global health problem without any effective therapy. Obesity
is characterized by low-grade inflammation, which predisposes individuals to metabolic …